Market Cap

Hubei Goto Biopharm Co.,Ltd. Market Capitalization:

CN¥2.34 Billion

CNY as of Jan. 1, 2026

US$334.2 Million

business Hubei Goto Biopharm Co.,Ltd. Company Profile

Hubei Goto Biopharm Co.,Ltd. Main Stock Listing

SZSE: 300966

Market Capitalization History of Hubei Goto Biopharm Co.,Ltd.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $158.96 B
Vertex Pharmaceuticals Incorporated $115.92 B
CSL Limited $95.75 B
Regeneron Pharmaceuticals, Inc. $82.28 B
Marinomed Biotech AG $70.11 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Yearly evolution of Hubei Goto Biopharm Co.,Ltd. market cap

Date Market Cap YoY Change
Jan. 1, 2026 CN¥2.34 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Hubei Goto Biopharm Co.,Ltd. Categories

China languages Healthcare languages Biotechnology
China Healthcare China Biotechnology

Stocks & Indices

Hubei Goto Biopharm Co.,Ltd. has the following listings and related stock indices.


Stock: SZSE: 300966

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.